Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
39.24-0.11 (-0.28%)
As of 11:50AM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 39.35 |
| Open | 39.19 |
| Bid | 39.25 x 1000 |
| Ask | 39.27 x 1200 |
| Day's Range | 39.01 - 39.31 |
| 52 Week Range | 33.32 - 46.55 |
| Volume | 45,948 |
| Avg. Volume | 502,548 |
| Market Cap | 22.904B |
| Beta (5Y Monthly) | 0.99 |
| PE Ratio (TTM) | 16.47 |
| EPS (TTM) | 2.38 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.72 (1.82%) |
| Ex-Dividend Date | Aug 28, 2020 |
| 1y Target Est | 37.57 |
- Insider Monkey
Fresenius Medical (FMS) is a “Dependable Top-Line Grower”, Says Fiduciary Management
Fiduciary Management Inc., an investment management firm, published its “International Equity” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 7.2% (currency hedged) was reported by the FMI International portfolios for the Q1 of 2021, compared to its MSCI EAFE benchmark that delivered a 7.59% return in […]
- Zacks
DaVita (DVA) Partners With Fresenius, Boost Home Dialysis Care
DaVita's (DVA) recent collaboration will help patients benefit from the portability, dependability and flexibility of NxStage home machines, designed to be easy to use.
- Yahoo Finance
'Unless we vaccinate the entire planet, we won't get rid of this pandemic:' Vaccine developer
Controversial billionaire scientist Dr. Patrick Soon-Shiong discusses COVID-19 vaccine efforts.
© 2021 Verizon Media. All rights reserved.
